Search
EHT899
go.drugbank.com/drugs/DB05108ExperimentalIt also apparently enhances a secondary immune response to clear the viral infection, resulting in reduction in liver damage and decrease in viral load. … EHT899 is a proprietary formulation of an HBV viral protein designed to eliminate the undesirable immune response elicited by the HBV infection.
Chloride ion
go.drugbank.com/drugs/DB14547InvestigationalMixtures: VAMIN 14 IV AMINOASIT SOLÜSYONU, 500 ML, POLİFLEKS LAKTATLI RİNGER IV İNFÜZYON İÇİN ÇÖZELTİ, 1000 CC SETLISynonyms: Chloride ion, Chloride (ion)Malachite Green
go.drugbank.com/drugs/DB03895ExperimentalCategories: Compounds used in a research, industrial, or household settingIndole-3-Glycerol Phosphate
go.drugbank.com/drugs/DB04143ExperimentalCategories: Compounds used in a research, industrial, or household settingBromopyruvate
go.drugbank.com/drugs/DB17135ExperimentalCategories: Compounds used in a research, industrial, or household settingHematoxylin
go.drugbank.com/drugs/DB16871ExperimentalCategories: Compounds used in a research, industrial, or household settingTrolnitrate
go.drugbank.com/drugs/DB13719ExperimentalCategories: Vasodilators Used in Cardiac DiseasesETC-1001
go.drugbank.com/drugs/DB05866ExperimentalETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders.
Etrolizumab
go.drugbank.com/drugs/DB12189Investigational[A244574] In the case of [natalizumab], which targets the α4 integrin subunit, this has also resulted in undesirable blockade of lymphocyte CNS trafficking and reported cases of progressive multifocal … Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, is typified by a chronic gastrointestinal inflammatory microenvironment, driven in part by the excessive infiltration